Beijing Entaiwei Medicine Science Technology Co. Ltd. has described prodrugs of β-D-N4-hydroxycytidine reported to be useful for the treatment of viral infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback